BGC vs FULT

BGC has a stable Piotroski F-Score of 6/9, indicating moderate financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock shows strong revenue and earnings growth, with a high ROE of 14.56%, yet trades at a premium valuation (P/E 27.84 vs sector avg 22.39) despite a low Graham Number of $3.82, suggesting overvaluation on a defensive basis. While analyst consensus is strong_buy, insider selling worth $5.82M and a bearish technical trend signal caution. The fair value estimate is adjusted above the Graham Number due to growth metrics but tempered by leverage and weak technicals.

FULT presents a stark contrast between deep value and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the stock trades at a significant discount to both its Graham Number ($29.29) and Intrinsic Value ($61.36), the bearish technical trend and insider selling suggest caution. Strong earnings growth (46.5% YoY) and a consistent track record of beating estimates provide a bullish counter-narrative, but the low health score indicates underlying operational or financial instability. Overall, it is a high-value play with concerning health metrics.